ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this pill stop Alzheimer's before it starts? new trial targets gene carriers
Prevention Not yet recruitingThis study tests an experimental drug, HT-4253, to see if it can lower the risk of Alzheimer's disease in people who carry the APOE4 gene and have early signs of brain changes. About 112 participants aged 50-75 will take either the drug or a placebo for 48 weeks. The goal is to m…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Jun 17, 2026 02:43 UTC
-
New hope for Alzheimer's: safety trial of Add-On therapy begins
Symptom relief Not yet recruitingThis study tests whether adding an experimental drug (X/T+X-EC) to standard Alzheimer's treatment (lecanemab) is safe and tolerable. About 60 adults with Alzheimer's will receive either the drug or a placebo for 24 weeks. The main goal is to check for side effects, not to measure…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Symptom relief
Last updated Jun 12, 2026 12:04 UTC